4.3 Review

Optical coherence tomography of the pulmonary arteries: A systematic review

期刊

JOURNAL OF CARDIOLOGY
卷 67, 期 1-2, 页码 6-14

出版社

ELSEVIER
DOI: 10.1016/j.jjcc.2015.09.024

关键词

Optical coherence tomography; Pulmonary hypertension; Pulmonary artery; Chronic thromboembolic pulmonary hypertension; Pulmonary arterial hypertension

资金

  1. St. Jude Medical, Portugal
  2. Foundation for Science and Technology (FCT) [SFRH/SINTD/60113/2009]

向作者/读者索取更多资源

Optical coherence tomography (OCT) is an imaging technique extensively used for visualizing the coronary circulation, where it assists clinical decision-making. Along with the new interventional procedures being introduced for pulmonary vascular disease, there is an increasing need for intravascular imaging of the pulmonary arteries. Additionally, measurements of the wall thickness of the pulmonary arteries of patients with various types of pulmonary hypertension (PH) may provide relevant diagnostic and prognostic information. The aim of this review is to summarize all the available evidence on the use of OCT for imaging the pulmonary bed and to describe a simple protocol for OCT image acquisition. We conducted a systematic review of the literature using electronic reference databases through February 2015 (MEDLINE, Cochrane Library, Web of Knowledge, and references cited in other studies) and the search terms optical coherence tomography, pulmonary hypertension, and pulmonary arteries. Studies in which OCT was used to image the pulmonary vessels were considered for inclusion. We identified 14 studies reporting OCT imaging data from the pulmonary arteries. OCT was able to identify intravascular thrombi in patients with chronic thromboembolic PH (CTEPH), and an increase in vessel wall thickness was found in most patients with PH, compared with the controls. OCT has also been reported to be useful for the selection of balloon size in the setting of balloon pulmonary angioplasty for CTEPH. The main limitations include lack of standardization, little data on outcomes, cost, and the technical limitations involved in visualizing small-diameter (<1 mm) pulmonary vessels. OCT has become a potential tool for the in vivo study of vascular changes in the pulmonary arteries, and may provide additional information in the assessment of patients with PH. Prospective high-quality studies assessing the safety, validity, and clinical impact of OCT imaging for pulmonary vessels are warranted. (C) 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Rheumatology

Nonsteroidal Anti-inflammatory Drugs A Near-Death Experience

Joao Andre dos Santos Ferreira, Mariana Isabel Simao Fernandes Luis, Rui Miguel Terenas Lanca Baptista, Susana Isabel Monteiro Dias da Costa, Silvia Reis Monteiro, Lino Manuel Martins Goncalves

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2021)

Article Medicine, General & Internal

Usefulness of universal beta-blocker therapy in patients after ST-elevation myocardial infarction

Joao Andre Ferreira, Rui Miguel Baptista, Silvia Reis Monteiro, Lino Manuel Goncalves

Summary: The study findings suggest that the use of beta-blockers (BB) after ST-segment elevation myocardial infarction (STEMI) have not been proven beneficial in a 1-year follow-up, but may be beneficial in patients with reduced left ventricular ejection fraction.

MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

Long-Term Clinical and Hemodynamic Outcomes after Heart Transplantation in Patients Pre-Treated with Sildenafil

Sofia Lazaro Mendes, Nadia Moreira, Manuel Batista, Ana Rita Ferreira, Ana Vera Marinho, David Prieto, Rui Baptista, Susana Costa, Fatima Franco, Mariano Pego, Manuel de Jesus Antunes

Summary: The study showed that in patients with severe pulmonary hypertension pre-treated with sildenafil, early post-operative hemodynamics and prognosis were slightly worse than in patients without pulmonary hypertension, but after one year, the medium to long-term mortality proved to be similar.

ARQUIVOS BRASILEIROS DE CARDIOLOGIA (2021)

Article Cardiac & Cardiovascular Systems

Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry

Marius M. Hoeper, Miguel-Angel Gomez Sanchez, Marc Humbert, David Pittrow, Gerald Simonneau, Henning Gall, Ekkehard Gruenig, Hans Klose, Michael Halank, David Langleben, Repke J. Snijder, Pilar Escribano Subias, Lisa M. Mielniczuk, Tobias J. Lange, Jean-Luc Vachiery, Hubert Wirtz, Douglas S. Helmersen, Iraklis Tsangaris, Joan A. Barbera, Joanna Pepke-Zaba, Anco Boonstra, Stephan Rosenkranz, Silvia Ulrich, Regina Steringer-Mascherbauer, Marion Delcroix, Pavel Jansa, Iveta Simkova, George Giannakoulas, Jens Klotsche, Evgenia Williams, Christian Meier, Hossein-Ardeschir Ghofrani

Summary: The EXPERT study monitored the long-term safety of riociguat in clinical practice, showing consistent safety with clinical trials and no new safety concerns, with a lower exposure-adjusted rate of hemoptysis/pulmonary hemorrhage compared to the Phase 3 trial in PAH.

RESPIRATORY MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry

Hossein-Ardeschir Ghofrani, Miguel-Angel Gomez Sanchez, Marc Humbert, David Pittrow, Gerald Simonneau, Henning Gall, Ekkehard Gruenig, Hans Klose, Michael Halank, David Langleben, Repke J. Snijder, Pilar Escribano Subias, Lisa M. Mielniczuk, Tobias J. Lange, Jean-Luc Vachiery, Hubert Wirtz, Douglas S. Helmersen, Iraklis Tsangaris, Joan A. Barbera, Joanna Pepke-Zaba, Anco Boonstra, Stephan Rosenkranz, Silvia Ulrich, Regina Steringer-Mascherbauer, Marion Delcroix, Pavel Jansa, Iveta Simkova, George Giannakoulas, Jens Klotsche, Evgenia Williams, Christian Meier, Marius M. Hoeper

Summary: The EXPERT study, involving 956 CTEPH patients, demonstrated that the safety of riociguat in these patients was consistent with the known safety profile of the drug, with no new safety concerns identified.

RESPIRATORY MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

Impact of catheter ablation for atrial fibrillation in patients with heart failure and left ventricular systolic dysfunction

Joana Maria Ribeiro, Pedro A. Sousa, Natalia Antonio, Rui Baptista, Luis Elvas, Sergio Barra, Lino Goncalves

Summary: This observational study evaluated the impact of atrial fibrillation (AF) ablation on patients with heart failure (HF) and left ventricular (LV) systolic dysfunction. The results showed that AF ablation not only improved LVEF, but also led to improvements in functional status and favorable structural remodeling of the heart.

REVISTA PORTUGUESA DE CARDIOLOGIA (2021)

Article Cardiac & Cardiovascular Systems

Atrial Mechanics in Hypertrophic Cardiomyopathy: Discriminating between Ventricular Hypertrophy and Fibrosis

Patricia Marques-Alves, Joao Andre Ferreira, Andre Azul Freitas, Jose Paulo Almeida, Rui Baptista, Graca Castro, Rui Martins, Paulo Donato, Maria Joao Ferreira, Lino Goncalves

Summary: This study aimed to investigate left atrial functional abnormalities in hypertrophic cardiomyopathy (HCM) and hypertension patients, and determine their correlation with the extent of left ventricular fibrosis. The results showed that patients with HCM had significantly reduced left atrial mechanics, while patients with hypertension maintained normal left atrial function. Left atrial strain parameters were sensitive and specific for identifying HCM. Additionally, left atrial strain rate was associated with the degree of left ventricular fibrosis.

ARQUIVOS BRASILEIROS DE CARDIOLOGIA (2022)

Article Biochemistry & Molecular Biology

Incidence of Bloodstream Infection in Patients with Pulmonary Hypertension under Intravenous Epoprostenol or Iloprost-A Multicentre, Retrospective Study

Raquel Paulinetti Camara, Francisco das Neves Coelho, Natalia Cruz-Martins, Patricia Marques-Alves, Graca Castro, Rui Baptista, Filipa Ferreira

Summary: This study compares the incidence rates of bloodstream infection (BSI) between intravenous iloprost and epoprostenol administration. It shows that patients receiving iloprost are at a higher risk of developing BSI, with a higher mortality rate, and a higher incidence of BSI due to Gram-negative and low-virulence bacteria.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Editorial Material Cardiac & Cardiovascular Systems

Detailed safety analysis of DIAMOND trial: 'primum non nocere'?

Rui Baptista, Sara Goncalves, Ricardo Fontes-Carvalho

EUROPEAN HEART JOURNAL (2023)

Article Cardiac & Cardiovascular Systems

Pulmonary arterial hypertension unveils itself: a cancer-like progression - a case report

Catia Santos-Ferreira, Daniela Cardoso, Benedita Paiva, Rui Baptista

Summary: This case highlights the challenges of timely diagnosis of PAH, particularly the importance of genetic screening. Despite a temporary improvement in clinical symptoms, there is still a risk of rapid progression in patients with severe haemodynamic changes.

EUROPEAN HEART JOURNAL-CASE REPORTS (2021)

Article Medicine, General & Internal

Investigating the Usefulness of European Society of Cardiology Guidelines for Hospitalization in Acute Pericarditis at a Single Tertiary Center

Joao Ferreira, Mariana Luis, Rui Baptista, Silvia Monteiro, Lino Goncalves

Summary: This study retrospectively analyzed patients with acute pericarditis admitted to the emergency department from 2009 to 2019, identifying predictors of pericarditis recurrence. Despite discrepancies between clinical decisions and ESC guidelines, it did not lead to different outcomes.

CUREUS JOURNAL OF MEDICAL SCIENCE (2021)

Meeting Abstract Cardiac & Cardiovascular Systems

Acute pericarditis: who should stay and who should go?

J. Ferreira, M. Luis, R. Baptista, S. Monteiro, L. Goncalves

EUROPEAN HEART JOURNAL (2020)

Meeting Abstract Cardiac & Cardiovascular Systems

An invasive strategy is associated with improved short- and long-term outcomes in acute myocardial infarction independently of frailty status and GRACE score: a nationwide analysis of 12144 episodes

G. Pessoa Amorim, D. Santos-Ferreira, A. Azul Freilas, H. Santos, A. Belo, C. Gavina, R. Terenas Baptista, S. Monteiro

EUROPEAN HEART JOURNAL (2020)

Meeting Abstract Cardiac & Cardiovascular Systems

A real world analysis of NSTE-ACS in more than 4000 patients: accuracy of GRACE and TIMI scores in mortality prediction

J. Borges-Rosa, J. Ferreira, M. Oliveira-Santos, S. Monteiro, F. Goncalves, R. Monteiro, R. Baptista, L. Goncalves

EUROPEAN HEART JOURNAL (2020)

Review Cardiac & Cardiovascular Systems

Micro-RNA Analysis in Pulmonary Arterial Hypertension Current Knowledge and Challenges

Catia A. Santos-Ferreira, Monica T. Abreu, Carla Marques, Lino M. Goncalves, Rui Baptista, Henrique M. Girao

JACC-BASIC TO TRANSLATIONAL SCIENCE (2020)

Review Cardiac & Cardiovascular Systems

The mechanism of the NFAT transcription factor family involved in oxidative stress response

Peiyue Zhang, Cuiyuan Huang, Haiyin Liu, Mengting Zhang, Li Liu, Yuhong Zhai, Jing Zhang, Jian Yang, Jun Yang

Summary: NFAT is a widely expressed transcriptional activator that is involved in regulating the immune system, heart and brain development, and mediating pathological processes such as cardiac hypertrophy. Oxidative stress, characterized by excessive production of reactive oxygen species, mitochondrial dysfunction, calcium overload, and subsequent lipid peroxidation, inflammation, and apoptosis, is associated with various pathological processes. Calcium overload activates NFAT through the calcium-calcineurin pathway, which is the main regulatory mode of NFAT factors. This review focuses on the effects of NFAT transcription factors on reactive oxygen species production, calcium overload, mitochondrial dysfunction, redox reactions, lipid peroxidation, inflammation, and apoptosis in response to oxidative stress. The aim is to provide a reference for understanding the functions and characteristics of NFAT in different stages of oxidative stress and related potential targets.

JOURNAL OF CARDIOLOGY (2024)